Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma

Published:2005 Issue:5 Volume:103 Page:970-977
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Rigacci Luigi,Carrai Valentina,Nassi Luca,Alterini Renato,Longo Giovanni,Bernardi Franco,Bosi Alberto

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Treatment of Non-Hodgkin's Lymphoma

2. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

3. Interpretation of clinical trials in diffuse large-cell lymphoma.

4. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

5. CHOP may have been part of the beginning but certainly not the end: issues in risk-related therapy of large-cell lymphoma.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy;Current Treatment Options in Gastroenterology;2016-10-05

2. Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT;Drug Design, Development and Therapy;2016-08

3. Dose-Dense CHOP plus Rituximab (R-CHOP14) for the Treatment of Elderly Patients with High-Risk Diffuse Large B Cell Lymphoma: A Pilot Study;Acta Haematologica;2006

4. Current Awareness in Hematological Oncology;Hematological Oncology;2005-09-26

5. Alkylating Agents;Anticancer Therapeutics